Streetbeat News

Revenues

NWL

Newell Brands (NASDAQ:NWL), the maker of Sharpie pens, is shifting some of its production out of China to reduce tariff uncertainties. The company will relocate its writing business manufacturing to Tennessee and move kitchen appliance manufacturing to Vietnam, Thailand, Indonesia, and other locations. This strategic move aims to reduce Newell's dependence on China, automate U.S. manufacturing, and save on time and fluctuating freight costs.

Portfolio Pulse from Benzinga Neuro

August 07, 2024 | 11:34 am

PAYO

Payoneer Global has updated its FY24 guidance, projecting revenue between $920M and $930M, up from the prior estimate of $895M-$905M. Transaction costs are expected to be around 16.5% of revenue, down from the previous 17.5%. Adjusted EBITDA is forecasted to be between $225M and $235M, an increase from the prior $200M-$210M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:34 am

IMXI

IntL Money Express (NASDAQ:IMXI) reported Q2 earnings of $0.55 per share, missing the analyst estimate of $0.57. Sales were $171.53M, below the $174.62M estimate. Despite the misses, earnings and sales increased year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:34 am

EHTH

eHealth has projected its FY24 revenue to be between $470 million and $495 million, surpassing the estimated $466.574 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:33 am

ZVIA

Zevia expects Q3 net sales to be between $37 million and $40 million, which is below the estimated $44.29 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:33 am

VSTS

Vestis (NYSE:VSTS) reported Q3 2024 adjusted EPS of $0.16, beating the $0.11 estimate by 45.45%. Sales were $698.248M, surpassing the $689.113M estimate by 1.33%. However, both EPS and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:33 am

ITCI

Intra-Cellular Therapies has projected its 2024 net product sales for CAPLYTA to be between $650 million and $680 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:32 am

PAYO

Payoneer Global reported its Q2 2024 financial results, with GAAP EPS of $0.09 beating the $0.05 estimate and sales of $239.520 million surpassing the $223.079 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:31 am

ITCI

Intra-Cellular Therapies (NASDAQ:ITCI) reported Q2 2024 GAAP EPS of $(0.16), beating the estimate of $(0.20). Sales were $161.4M, surpassing the $157.88M estimate and marking a 45.68% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:31 am

ZVIA

Zevia continues to expect FY24 net sales in the range of $158M to $166M, aligning with the estimated $162.365M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:30 am